TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2−/−-Driven Myeloid Malignancy Progression

Rong Li, Yuan Zhou, Zeng Cao, Lin Liu, Jinhuan Wang, Zizhen Chen, Wen Xing, Shi Chen, Jie Bai, Weiping Yuan, Tao Cheng, Mingjiang Xu, Feng-Chun Yang, Zhigang Zhao

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

TET2 is a methylcytosine dioxygenase that regulates cytosine hydroxymethylation. Although there are extensive data implicating a pivotal role of TET2 in hematopoietic stem/progenitor cells (HSPCs), the importance of TET2 in bone marrow mesenchymal stromal cells (BMSCs) remains unknown. In this study, we show that loss of TET2 in BMSCs increases cell proliferation and self-renewal and enhances osteoblast differentiation potential of BMSCs, which may in turn alter their behavior in supporting HSPC proliferation and differentiation. In addition, Tet2 loss alters BMSCs in promoting Tet2-deficiency-mediated myeloid malignancy progression. Tet2 loss in BMSCs also dysregulates hydroxylation of 5-methylcytosine (5mC) and the expression of genes that are key for BMSC proliferation and osteoblast differentiation, leading to alteration of biological characteristics in vivo. These results highlight the critical role of TET2 in the maintenance of BMSC functions and osteoblast differentiation and provide evidence that dysregulation of epigenetic modifiers in BMSCs contributes to the progression of myeloid malignancies. In this article, Zhao and colleagues demonstrated that TET2 plays an important role in regulating the behavior of BMSCs in addition to its intrinsic role in HSPCs to participate in aberrant hematopoiesis. Moreover, they also show that BMSCs are the most important niche cell components in Tet2−/− mice that contribute to the progression of Tet2-deletion-driven myeloid malignancies.

Original languageEnglish (US)
Pages (from-to)166-179
Number of pages14
JournalStem Cell Reports
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Mesenchymal Stromal Cells
Bone
Neoplasms
Osteoblasts
Cell proliferation
Hematopoietic Stem Cells
Stem cells
5-Methylcytosine
Dioxygenases
Hydroxylation
Cytosine
Cell Proliferation
Genes
Hematopoiesis
Cellular Structures

Keywords

  • bone marrow mesenchymal stromal cells
  • bone marrow niche
  • myeloid malignancies
  • TET2

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Developmental Biology
  • Cell Biology

Cite this

TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2−/−-Driven Myeloid Malignancy Progression. / Li, Rong; Zhou, Yuan; Cao, Zeng; Liu, Lin; Wang, Jinhuan; Chen, Zizhen; Xing, Wen; Chen, Shi; Bai, Jie; Yuan, Weiping; Cheng, Tao; Xu, Mingjiang; Yang, Feng-Chun; Zhao, Zhigang.

In: Stem Cell Reports, Vol. 10, No. 1, 01.01.2018, p. 166-179.

Research output: Contribution to journalArticle

Li, Rong ; Zhou, Yuan ; Cao, Zeng ; Liu, Lin ; Wang, Jinhuan ; Chen, Zizhen ; Xing, Wen ; Chen, Shi ; Bai, Jie ; Yuan, Weiping ; Cheng, Tao ; Xu, Mingjiang ; Yang, Feng-Chun ; Zhao, Zhigang. / TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2−/−-Driven Myeloid Malignancy Progression. In: Stem Cell Reports. 2018 ; Vol. 10, No. 1. pp. 166-179.
@article{730a636c0d90495d9b55e3b6bb01beda,
title = "TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2−/−-Driven Myeloid Malignancy Progression",
abstract = "TET2 is a methylcytosine dioxygenase that regulates cytosine hydroxymethylation. Although there are extensive data implicating a pivotal role of TET2 in hematopoietic stem/progenitor cells (HSPCs), the importance of TET2 in bone marrow mesenchymal stromal cells (BMSCs) remains unknown. In this study, we show that loss of TET2 in BMSCs increases cell proliferation and self-renewal and enhances osteoblast differentiation potential of BMSCs, which may in turn alter their behavior in supporting HSPC proliferation and differentiation. In addition, Tet2 loss alters BMSCs in promoting Tet2-deficiency-mediated myeloid malignancy progression. Tet2 loss in BMSCs also dysregulates hydroxylation of 5-methylcytosine (5mC) and the expression of genes that are key for BMSC proliferation and osteoblast differentiation, leading to alteration of biological characteristics in vivo. These results highlight the critical role of TET2 in the maintenance of BMSC functions and osteoblast differentiation and provide evidence that dysregulation of epigenetic modifiers in BMSCs contributes to the progression of myeloid malignancies. In this article, Zhao and colleagues demonstrated that TET2 plays an important role in regulating the behavior of BMSCs in addition to its intrinsic role in HSPCs to participate in aberrant hematopoiesis. Moreover, they also show that BMSCs are the most important niche cell components in Tet2−/− mice that contribute to the progression of Tet2-deletion-driven myeloid malignancies.",
keywords = "bone marrow mesenchymal stromal cells, bone marrow niche, myeloid malignancies, TET2",
author = "Rong Li and Yuan Zhou and Zeng Cao and Lin Liu and Jinhuan Wang and Zizhen Chen and Wen Xing and Shi Chen and Jie Bai and Weiping Yuan and Tao Cheng and Mingjiang Xu and Feng-Chun Yang and Zhigang Zhao",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.stemcr.2017.11.019",
language = "English (US)",
volume = "10",
pages = "166--179",
journal = "Stem Cell Reports",
issn = "2213-6711",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2−/−-Driven Myeloid Malignancy Progression

AU - Li, Rong

AU - Zhou, Yuan

AU - Cao, Zeng

AU - Liu, Lin

AU - Wang, Jinhuan

AU - Chen, Zizhen

AU - Xing, Wen

AU - Chen, Shi

AU - Bai, Jie

AU - Yuan, Weiping

AU - Cheng, Tao

AU - Xu, Mingjiang

AU - Yang, Feng-Chun

AU - Zhao, Zhigang

PY - 2018/1/1

Y1 - 2018/1/1

N2 - TET2 is a methylcytosine dioxygenase that regulates cytosine hydroxymethylation. Although there are extensive data implicating a pivotal role of TET2 in hematopoietic stem/progenitor cells (HSPCs), the importance of TET2 in bone marrow mesenchymal stromal cells (BMSCs) remains unknown. In this study, we show that loss of TET2 in BMSCs increases cell proliferation and self-renewal and enhances osteoblast differentiation potential of BMSCs, which may in turn alter their behavior in supporting HSPC proliferation and differentiation. In addition, Tet2 loss alters BMSCs in promoting Tet2-deficiency-mediated myeloid malignancy progression. Tet2 loss in BMSCs also dysregulates hydroxylation of 5-methylcytosine (5mC) and the expression of genes that are key for BMSC proliferation and osteoblast differentiation, leading to alteration of biological characteristics in vivo. These results highlight the critical role of TET2 in the maintenance of BMSC functions and osteoblast differentiation and provide evidence that dysregulation of epigenetic modifiers in BMSCs contributes to the progression of myeloid malignancies. In this article, Zhao and colleagues demonstrated that TET2 plays an important role in regulating the behavior of BMSCs in addition to its intrinsic role in HSPCs to participate in aberrant hematopoiesis. Moreover, they also show that BMSCs are the most important niche cell components in Tet2−/− mice that contribute to the progression of Tet2-deletion-driven myeloid malignancies.

AB - TET2 is a methylcytosine dioxygenase that regulates cytosine hydroxymethylation. Although there are extensive data implicating a pivotal role of TET2 in hematopoietic stem/progenitor cells (HSPCs), the importance of TET2 in bone marrow mesenchymal stromal cells (BMSCs) remains unknown. In this study, we show that loss of TET2 in BMSCs increases cell proliferation and self-renewal and enhances osteoblast differentiation potential of BMSCs, which may in turn alter their behavior in supporting HSPC proliferation and differentiation. In addition, Tet2 loss alters BMSCs in promoting Tet2-deficiency-mediated myeloid malignancy progression. Tet2 loss in BMSCs also dysregulates hydroxylation of 5-methylcytosine (5mC) and the expression of genes that are key for BMSC proliferation and osteoblast differentiation, leading to alteration of biological characteristics in vivo. These results highlight the critical role of TET2 in the maintenance of BMSC functions and osteoblast differentiation and provide evidence that dysregulation of epigenetic modifiers in BMSCs contributes to the progression of myeloid malignancies. In this article, Zhao and colleagues demonstrated that TET2 plays an important role in regulating the behavior of BMSCs in addition to its intrinsic role in HSPCs to participate in aberrant hematopoiesis. Moreover, they also show that BMSCs are the most important niche cell components in Tet2−/− mice that contribute to the progression of Tet2-deletion-driven myeloid malignancies.

KW - bone marrow mesenchymal stromal cells

KW - bone marrow niche

KW - myeloid malignancies

KW - TET2

UR - http://www.scopus.com/inward/record.url?scp=85042379267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042379267&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2017.11.019

DO - 10.1016/j.stemcr.2017.11.019

M3 - Article

C2 - 29290626

AN - SCOPUS:85042379267

VL - 10

SP - 166

EP - 179

JO - Stem Cell Reports

JF - Stem Cell Reports

SN - 2213-6711

IS - 1

ER -